Iktos

Iktos is a French AI company specializing in generative AI for new drug design, combining its Makya de novo molecular design platform with the Spaya retrosynthesis engine and robotic chemistry capabilities. The company has established over 60 collaborations with pharmaceutical and biotech companies, applying its AI tools across the full small molecule design cycle from hit generation to lead optimization.

60+ pharma collaborations

Makya is a generative AI platform for de novo drug design that creates novel molecules with desired properties. Spaya is an AI retrosynthesis engine that predicts synthetic routes for designed molecules. Together with robotic chemistry, they form a closed-loop design-make-test cycle.